Indeed, BRAF inhibitors enhance β-catenin nuclear accumulation through the induction of BRAF-CRAF heterodimerization and subsequent activation of ERK signaling in both CAFs and melanoma cells, leading to proliferation of melanoma cells [101]. Here, BRAF is linked to melanoma.